Waters Corp

Most Recent

  • uploads///Chart
    Macroeconomic Analysis

    Huntington Bancshares Landed at the Bottom of SPY on Merger Deal

    Huntington Bancshares (HBAN) plunged 8.5% on Tuesday, January 26, after the bank announced its plan to acquire FirstMerit (FMER) in a deal worth $3.4 billion.

    By Renee Blakely
  • uploads///Part  Graph
    Company & Industry Overviews

    Waters Introduces Symphony, Its New Data Pipeline Software

    A top IHI performer on June 2, 2016, was Waters (WAT), which rose 0.9%. The company was in the news with the introduction of its new data pipeline software.

    By Peter Neil
  • uploads///FIS
    Consumer

    Cantillon ups its stake in Fidelity National Information Services

    Cantillon increased its position in Fidelity National Information Services Inc. (FIS), which now accounts for 9.58% of its total portfolio in 1Q 2014 from 6.8% in the prior quarter.

    By Samantha Nielson
  • uploads///WAT SGA
    Company & Industry Overviews

    Exploring Waters Corporation’s Operational Performance

    Waters Corporation (WAT) incurred selling and administrative expenses of $136.6 million in the second quarter.

    By Kenneth Smith
  • uploads///CantQ
    Consumer

    Cantillon Capital Management’s 1Q 2014 investment strategy

    The New York–based Cantillon Capital Management filed its 13F for the first quarter of 2014. The size of the U.S. long portfolio slightly increased in the quarter, from $4.22 billion to $4.32 billion.

    By Samantha Nielson
  • uploads///TMO
    Company & Industry Overviews

    Do Analysts See Any Upside for Thermo Fisher Stock?

    Of the 17 analysts covering Thermo Fisher Scientific (TMO), 14 recommend ” buy” or a higher rating, and three recommend “hold.”

    By Kenneth Smith
  • uploads///TMO
    Company & Industry Overviews

    Thermo Fisher Scientific’s Gross Margin Trends

    In fiscal 2018 and fiscal 2019, Thermo Fisher Scientific (TMO) is expected to generate revenue of $24.08 billion and $25.19 billion, respectively, compared with revenue of $20.92 billion in fiscal 2017.

    By Kenneth Smith
  • uploads///ILMN
    Company & Industry Overviews

    Analysts Remain Bullish on Illumina Stock

    In November, of the 19 analysts covering Illumina (ILMN), 14 have given it “buy” or higher ratings, and five have given it “hold” ratings.

    By Kenneth Smith
  • uploads///ILMN
    Company & Industry Overviews

    Understanding Illumina’s Gross Margin Trend

    Illumina’s cost of product revenue increased from $173.0 million in the third quarter of 2017 to $184.0 million in the third quarter of 2018.

    By Kenneth Smith
  • uploads///ILMN
    Company & Industry Overviews

    Understanding Illumina’s Geographical Performance

    For 2018 and 2019, Illumina is expected to generate revenues of $3.33 billion and $3.80 billion, respectively.

    By Kenneth Smith
  • uploads///WAT ana reco
    Company & Industry Overviews

    What Waters Corporation’s Valuation Trend Indicates

    In September, of the 15 analysts covering Waters Corporation (WAT) stock, ten have given it “holds.”

    By Kenneth Smith
  • uploads///HPIC SYSTEM
    Company & Industry Overviews

    A Look at TMO’s New High Pressure Ion Chromatography System

    On February 27, 2018, Thermo Fisher Scientific (TMO) announced the launch of its new high-pressure Ion Chromatography System.

    By Sarah Collins
  • uploads///R RFT
    Company & Industry Overviews

    ROP’s Second-Largest Segment: Radio Frequency Technology

    In 2015, ROP’s Radio Frequency Technology segment contributed ~28.9% to its total consolidated revenue and ~30.4% to its consolidated operating profit

    By Jessica Stephans
  • uploads///Roper key acqusi
    Company & Industry Overviews

    Roper Technologies: Recent Acquisitions That Count

    Since its inception, Roper Technologies (ROP) has followed an acquisition-based growth strategy. The company has acquired over 50 companies since 1981.

    By Jessica Stephans
  • uploads///riisskkss
    Company & Industry Overviews

    What Risks Does Roper Technologies Face?

    Roper Technologies’ growth strategy includes acquisitions. Its growth largely depends on its ability to acquire and successfully integrate new businesses.

    By Jessica Stephans
  • uploads///Part  Graph
    Company & Industry Overviews

    How Are IHI’s Holdings’ Moving Averages Trending?

    IHI has 47 stocks in its portfolio. As of June 9, 2016, 94% of IHI’s stocks were trading above their 20-day moving averages.

    By Peter Neil
  • uploads///Part  Graph
    Company & Industry Overviews

    IHI’s Large-Cap Stocks Continue to Impress

    IHI’s large-cap stocks have been impressive in their performances and have remained positive in May 2016.

    By Peter Neil
  • uploads///Part  Graph
    Company & Industry Overviews

    As IHI Keeps Surging, Which Are the Top Performers?

    The markets fell today as oil took a dive. The Dow Jones Industrial Average fell 0.6%, and the SPDR S&P 500 ETF (SPY) fell 0.5%.

    By Peter Neil
  • uploads///segmentation
    Company & Industry Overviews

    An Overview of Thermo Fisher Scientific’s Business Model

    Thermo Fisher Scientific (TMO) has made a number of acquisitions over the years, resulting in the expansion of the company’s product portfolio with the inclusion of a number of premium brands.

    By Sarah Collins
  • uploads///Graph Part  Dec
    Company & Industry Overviews

    Waters Led XLV’s Electronic Subgroup

    Waters closed at $133.73 and was trading above its 100-day moving average price of $126.45, and it was also trading above its 20-day moving average price of $131.44.

    By Peter Neil
  • uploads///Graph Part  Oct
    Company & Industry Overviews

    Natus and Masimo Helped IHI’s Top Ten Small-Cap Stocks Outperform

    Natus (BABY) gained 1.9% and closed at $39.90. The stock is trading below its 20-day, 50-day, and 100-day moving averages.

    By Peter Neil
  • uploads///Graph Part  Oct
    Company & Industry Overviews

    Top Ten Mid-Cap Stocks Outperformed SPY on October 12

    Varian Medical Systems (VAR) fell by 1.5% and closed at $76.82 on October 12. The stock fell on profit booking, breaking its three-day upward trend.

    By Peter Neil
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.